FDA Inspection
Tolmar, Inc.Tolmar, Inc. – FDA Inspection, Jan 28, 2020
Record Details
This FDA Inspection record concerns Tolmar, Inc., with an inspection on January 28, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Tolmar, Inc.
- Inspection Date
- January 28, 2020
- Product Type
- Drugs
View Company Profile
ID · 9d184c96-c680-4738-8584-419de1feaf8c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1116204
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tolmar, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2024 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| January 31, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 6, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 6, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Tolmar, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.